Inventor · disambiguated record
Gary S. Jacob
Also filed as: JACOB GARY · JACOB GARY S
33 granted patents·17 pending applications·1,075 citations·filing 1988–2023
98Inventor score
Files withSYNERGY PHARMACEUTICALS INC18BAUSCH HEALTH IRELAND LTD8SEARLE & CO5SHAILUBHAI KUNWAR5MONSANTO CO3
Top patents by PatentIndex Score
50 records- 0198US7879802B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2008·Granted Feb 1, 2011·47 cites·6 claims
- 0297US8716224B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSHAILUBHAI KUNWAR·Filed 2011·Granted May 6, 2014·31 cites·5 claims
- 0397US8637451B2Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesisSHAILUBHAI KUNWAR·Filed 2011·Granted Jan 28, 2014·27 cites·3 claims
- 0497US8357775B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2012·Granted Jan 22, 2013·37 cites·4 claims
- 0597US8114831B2Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesisSHAILUBHAI KUNWAR·Filed 2010·Granted Feb 14, 2012·37 cites·4 claims
- 0697US7799897B2Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesisSYNERGY PHARMACEUTICALS INC·Filed 2006·Granted Sep 21, 2010·44 cites·4 claims
- 0797US7041786B2Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesisSYNERGY PHARMACEUTICALS INC·Filed 2002·Granted May 9, 2006·102 cites·6 claims
- 0896US8497348B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2012·Granted Jul 30, 2013·28 cites·4 claims
- 0996US8207295B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSHAILUBHAI KUNWAR·Filed 2009·Granted Jun 26, 2012·32 cites·3 claims
- 1095US9266926B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Feb 23, 2016·14 cites·6 claims
- 1195US9238677B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Jan 19, 2016·14 cites·12 claims
- 1295US8901075B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2013·Granted Dec 2, 2014·16 cites·6 claims
- 1395US6491903B1Particles comprising amphiphilic copolymersUNIV WASHINGTON·Filed 1997·Granted Dec 10, 2002·106 cites·76 claims
- 1495US5043273APhosphorylated glycosidase inhibitor prodrugsMONSANTO CO·Filed 1989·Granted Aug 27, 1991·65 cites·4 claims
- 1594US6225325B1Use of alkylated iminosugars to treat multidrug resistanceSEARLE & CO·Filed 1998·Granted May 1, 2001·79 cites·42 claims
- 1693US6696059B2Combination drug therapy for glycolipid storage diseasesSEARLE & CO·Filed 2002·Granted Feb 24, 2004·47 cites·9 claims
- 1793US6495570B2Combination drug therapy for glycolipid storage diseasesSEARLE & CO·Filed 2001·Granted Dec 17, 2002·47 cites·5 claims
- 1891US9914752B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·5 cites·11 claims
- 1991US5103008ACompound, N-butyl-deoxynojirimycin-6-phosphateMONSANTO CO·Filed 1991·Granted Apr 7, 1992·57 cites·1 claims
- 2087US9920095B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2015·Granted Mar 20, 2018·5 cites·12 claims
- 2187US7612093B2Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapyUNITED THERAPEUTICS CORP·Filed 2005·Granted Nov 3, 2009·3 cites·9 claims
- 2287US2024002440A1Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersBAUSCH HEALTH IRELAND LTD·Filed 2023·Application pending·0 cites
- 2386US6610703B1Method for treatment of glycolipid storage diseasesSEARLE & CO·Filed 1999·Granted Aug 26, 2003·71 cites·12 claims
- 2483US9545446B2Agonists of guanylate cyclase and their usesSYNERGY PHARMACEUTICALS INC·Filed 2014·Granted Jan 17, 2017·6 cites·13 claims
- 2582US9089515B2Long chain N-alkyl compounds and oxa-derivatives thereofZITZMANN NICOLE·Filed 2011·Granted Jul 28, 2015·9 cites·23 claims
- 2681US7816560B1Long chain n-alkyl compounds and oxa-derivatives thereofUNIV JEFFERSON·Filed 2000·Granted Oct 19, 2010·10 cites·4 claims
- 2777US6689759B1Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapySEARLE & CO·Filed 1998·Granted Feb 10, 2004·46 cites·55 claims
- 2876US6809083B1Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infectionsFiled 1999·Granted Oct 26, 2004·31 cites·3 claims
- 2975US2020283480A1Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersBAUSCH HEALTH IRELAND LTD·Filed 2020·Application pending·0 cites
- 3073US10967043B2Agonists of guanylate cyclase and their usesBAUSCH HEALTH IRELAND LTD·Filed 2019·Granted Apr 6, 2021·0 cites·8 claims
- 3173US10711038B2Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersBAUSCH HEALTH IRELAND LTD·Filed 2017·Granted Jul 14, 2020·0 cites·4 claims
- 3273US10342848B2Agonists of guanylate cyclase and their usesSYNERGY PHARMACEUTICALS INC·Filed 2016·Granted Jul 9, 2019·1 cites·10 claims
- 3372US4957926AMethod of treating herpesvirusesMONSANTO CO·Filed 1988·Granted Sep 18, 1990·40 cites·9 claims
- 3471US2020325176A1Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And CarcinogenesisBAUSCH HEALTH IRELAND LTD·Filed 2020·Application pending·0 cites
- 3570US2014121169A1Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And CarcinogenesisSYNERGY PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3669US2018273586A1Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3768US2021379142A1Agonists of guanylate cyclase and their usesBAUSCH HEALTH IRELAND LTD·Filed 2021·Application pending·0 cites
- 3864US10653744B2Formulations and methods for treating ulcerative colitisBAUSCH HEALTH IRELAND LTD·Filed 2017·Granted May 19, 2020·0 cites·7 claims
- 3963US2016340390A1Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disordersSYNERGY PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4061US2010120694A1Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other DisordersSYNERGY PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4160US2013274204A1Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other DisordersSYNERGY PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4258US2020316164A1Formulations and methods for treating ulcerative colitisBAUSCH HEALTH IRELAND LTD·Filed 2020·Application pending·0 cites
- 4356US2007015780A1Method of treating cancer with azaspirane compositionsPICKER DONALD H·Filed 2004·Application pending·0 cites
- 4455US2010137365A1Long chain N-alkyl compounds and oxa-derivatives thereofUNIV JEFFERSON·Filed 2010·Application pending·0 cites
- 4554US2005267153A1Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infectionsMUELLER RICHARD A·Filed 2004·Application pending·0 cites
- 4653US2014187470A1Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other DisordersSYNERGY PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4751US2005250801A1Method of treating cancer with azaspirane compositionsSHAILUBHAI KUNWAR·Filed 2004·Application pending·0 cites
- 4837US5776083AExercise device for use in the rehabilitative therapy of joint complexesFiled 1994·Granted Jul 7, 1998·18 cites·4 claims
- 4936US2010203146A1Intermittent dosing strategy for treating rheumatoid arthritisCALLISTO PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 5033US2003100532A1Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infectionsFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gary S. Jacob files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →